A cohort study of the association between metabolic syndrome and digestive system diseases including nonalcoholic fatty liver disease at medical check up

A cohort study of the association between metabolic syndrome and digestive system diseases including nonalcoholic fatty liver disease at medical check up - A study of the association between metabolic syndrome and digestive system diseases including nonalcoholic fatty liver disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025147

Enrollment

10000

Registered

2016-12-26

Start date

2017-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects who underwent a medical checkup and subjects with metabolic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who underwent a medical checkup or subjects with metabolic syndrome

Exclusion criteria

Exclusion criteria: <Subjects who fulfill the exclusion criteria for nonalcoholic fatty liver disease> 1. Subjects who were positive for hepatitis B surface antigen 2. Subjects who were positive for hepatitis C antibody 3. Subjects who had a history of various hepatic disorders 4. Subjects who consumed 20 g/day or more of alcohol 5. Subjects who had a malignant tumor <Subjects who fulfill the exclusion criteria for various digestive system diseases excluding nonalcoholic fatty liver disease> 1. Subjects who had a history of digestive organ surgery 2. Subjects who had a malignant tumor

Design outcomes

Primary

Measure	Time frame
The predictor of nonalcoholic fatty liver disease in subjects who underwent a medical checkup	—

Secondary

Measure	Time frame
1. The prevalence of nonalcoholic fatty liver disease in subjects who underwent a medical checkup or subjects with MS 2. The predictor of nonalcoholic fatty liver disease in subjects who underwent a medical checkup or subjects with MS 3. The prevalence of various digestive system diseases in subjects who underwent a medical checkup or subjects with MS 4. The predictor of various digestive system diseases in subjects who underwent a medical checkup or subjects with MS	—

Measure

Time frame

1. The prevalence of nonalcoholic fatty liver disease in subjects who underwent a medical checkup or subjects with MS 2. The predictor of nonalcoholic fatty liver disease in subjects who underwent a medical checkup or subjects with MS 3. The prevalence of various digestive system diseases in subjects who underwent a medical checkup or subjects with MS 4. The predictor of various digestive system diseases in subjects who underwent a medical checkup or subjects with MS

—

Countries

Japan

Contacts

Public ContactMasahiro Sogabe

Health Service Office, Health Service, Counseling and Accessibility Center, Tokushima University Health Service

sogabe.masahiro@tokushima-u.ac.jp088-656-7289

Outcome results